Need professional-grade analysis? Visit stockanalysis.com
$1.23B
73.53
999
N/A
Price Chart
Risk-Adjusted Performance
| Ratio | 1W | 1M | 3M | 6M | 1Y | 5Y | Score |
|---|---|---|---|---|---|---|---|
| Ulcer | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Medios AG (MEDOF) Price Performance
Medios AG (MEDOF) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at $50.00.
Over the past year, MEDOF has traded between a low of $50.00 and a high of $50.00.
Medios AG has a market capitalization of $1.23B, with a price-to-earnings ratio of 73.53.
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is headquartered in Berlin, Germany.
Company Info
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $2.01B
- EBITDA
- $76.02M
- Profit Margin
- 1.09%
- EPS (TTM)
- 0.68
- Book Value
- 24.06
Technical Indicators
- 52 Week High
- $50.00
- 52 Week Low
- $13.64
- 50 Day MA
- $50.00
- 200 Day MA
- $50.00
- Beta
- 1.10
Valuation
- Trailing P/E
- 73.53
- Forward P/E
- N/A
- Price/Sales
- 0.61
- Price/Book
- 3.25
- Enterprise Value
- $565.24M